|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0007138,
umls-concept:C0017262,
umls-concept:C0018188,
umls-concept:C0185117,
umls-concept:C0392752,
umls-concept:C0449258,
umls-concept:C0699885,
umls-concept:C1306673,
umls-concept:C1540292,
umls-concept:C2911684
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2007-5-14
|
|
pubmed:abstractText |
PD-L1 (programmed death ligand 1, B7-H1) is a cell surface glycoprotein that can impair T-cell function. PD-L1 is aberrantly expressed by multiple human malignancies and has been shown to carry a highly unfavorable prognosis in patients with kidney cancer. The role of PD-L1 was evaluated as a mechanism for local stage progression in urothelial carcinoma (UC) of the bladder.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
109
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1499-505
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17340590-Aged,
pubmed-meshheading:17340590-Antigens, CD,
pubmed-meshheading:17340590-Antigens, CD274,
pubmed-meshheading:17340590-Carcinoma, Transitional Cell,
pubmed-meshheading:17340590-Carcinoma in Situ,
pubmed-meshheading:17340590-Disease Progression,
pubmed-meshheading:17340590-Female,
pubmed-meshheading:17340590-Granuloma,
pubmed-meshheading:17340590-Humans,
pubmed-meshheading:17340590-Immunohistochemistry,
pubmed-meshheading:17340590-Immunotherapy,
pubmed-meshheading:17340590-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:17340590-Male,
pubmed-meshheading:17340590-Middle Aged,
pubmed-meshheading:17340590-Mycobacterium bovis,
pubmed-meshheading:17340590-Neoplasm Recurrence, Local,
pubmed-meshheading:17340590-Neoplasm Staging,
pubmed-meshheading:17340590-Transurethral Resection of Prostate,
pubmed-meshheading:17340590-Tumor Markers, Biological,
pubmed-meshheading:17340590-Urinary Bladder Neoplasms
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.
|
|
pubmed:affiliation |
Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
